About Takagi Clinic
"消化管（胃・小腸・大腸）の内視鏡検査・治療や造影検査、特に大腸がん、 ポリープ、炎症性腸疾患（潰瘍性大腸炎・クローン病）の診断・治療を得意分野とし、 検査機器や治療には、大きな病院の診療レベルと同等にするよう最新のものを取り入れています。 また、地元で診療を重ねた医院として、各医療機関と連携した豊かなネットワークがございますので、ご心配ごとはお気軽にご相談下さい。 （診療開始は、朝8時30分から。土曜日も午後3時まで診療しています。駐車場20台）"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Janssen Research & Development, LLC
2
Clinical Trials at Takagi Clinic
During the past decade, Takagi Clinic conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease
2016-12-14
2021-02-05
Completed
191
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
2018-06-18
2024-03-19
Recruiting
1,281
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
2018-07-18
2029-04-25
Recruiting
960
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
2018-10-19
2025-03-18
Active, not recruiting
1,177
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
2022-01-19
2025-08-14
Recruiting
318
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
2022-07-22
2030-10-08
Recruiting
715
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Takagi Clinic
According to Clinical.Site data, the most researched conditions in "Takagi Clinic" are
"Ulcerative Colitis" (3 trials), "Crohn's Disease" (2 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Takagi Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Takagi Clinic
Most popular intervention types in "Takagi Clinic" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Mirikizumab" (3 trials), "Golimumab" (1 trials), "Guselkumab" (1 trials) and "Guselkumab Dose 1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Takagi Clinic
The vast majority of trials in "Takagi Clinic" are
6 trials for "All" genders.
Clinical Trials Status at Takagi Clinic
Currently, there are NaN active trials in "Takagi Clinic".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Takagi Clinic,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Takagi Clinic, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".